Galapagos

Withdraw cancel rip up application
Biotech

Galapagos gets cold feet over plans to split up company

Only five months after Galapagos announced it would split in two, the cell-therapy-focused biotech is already having second thoughts.
James Waldron May 13, 2025 6:55am
Parachute over a mountain in Switzerland

Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders

Apr 25, 2025 8:30am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

AIRNA appoints Elevidys architect as CMO—Chutes & Ladders

Apr 18, 2025 8:30am
X ray illustration of a running person with pain in knee joint with blue background

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Apr 16, 2025 2:55pm
too many options

Adaptimmune questions own longevity, axes preclinical funding

Mar 20, 2025 2:04pm
Galapagos penguins rock meet water

Galapagos drops one CD19 CAR-T to focus on 'flagship' program

Feb 13, 2025 8:00am